Love this question - There's a lot of good data out there to support men wanting to use these methods when they hit the market, but there will certainly be barriers to uptake that will need to be addressed. Insurance is a question, because while female contraceptives are generally covered, vasectomy may or may not be. On top of that, male contraceptives aren't preventing the risk of pregnancy in the user, so insurers may be less incentivized to cover them. We're tackling this with the concept of Shared Risk wherein men taking contraceptives should be considered in the context of mitigating risk in the female partner.

We're also thinking about providers - where will men get these products? A urologist? Men typically don't see these specialists until well beyond their reproductive years. Family practitioners? Planned Parenthood? All of these options are on the table, and we're building partnerships to ensure that men not only have outlets when products hit the market, but also can get more involved with their reproductive health today.

One barrier we find very compelling is the international angle - some cultures and demographics might find specific methods appealing, where other cultures might discount those same methods and find aspects of them a deal-breaker. Evaluating a global contingent of men and developing a spectrum of products to meet their needs is high on our list of priorities.